The Official Portal for the State of Georgia

2004 Accomplishments - Enforcement

A few highlights of our achievements for consumers in the civil and criminal arena in 2004 are:

Credit Repair and Debt Adjustment


Deceptive Auto Sales and Advertising


Unfair and Deceptive Practices

  1. Misrepresented the identity of the business the consumer would contact in response to the ad;
  2. Misrepresented that the business had received a high rating from at least two consumer product rating groups, including Good Housekeeping;
  3. Misrepresented that the business is incorporated in Georgia;
  4. Misrepresented an affiliation with merchant companies, including Sears;
  5. Misrepresented that the business advertised is a local business;
  6. Failed to disclose the non-local address for the forwarded telephone numbers;
  7. Failed to honor the advertised price guarantees;
  8. Deceptively induced consumers with low misrepresented charges;
  9. Confused the consumer as to the business name by advertising in one name and billing in another name; and
  10. Willfully violated the terms of a 2001 AVC. 

The investigation revealed that the telephone lines were programmed to forward all incoming calls to BellSouth switching centers, where the lines are forwarded to undisclosed locations (all out of state).  The business was required to develop and implement new employee training procedures, as well as new marketing guidelines and procedures.  An AVC was entered incorporating the modified business practices and assessing a $20,000 civil penalty with consumer restitution.   (Filed July 2, 2004)

 

While the FDA has approved Neurontin only for certain treatment of epilepsy and shingles, approximately 90% of the time the aggressively-marketed drug was prescribed for other purposes not supported by scientific evidence, putting the health and safety of consumers at potential risk.

The settlement prohibits Warner-Lambert and Pfizer Inc. from:

  • Making false, misleading or deceptive oral or written claims about Neurontin;
  • Promoting off-label uses in violation of the federal Food, Drug and Cosmetic Act;
  • Misrepresenting the nature of scientific evidence concerning Neurontin;
  • Disseminating written materials that have not appeared in peer-reviewed scientific journals;
  • Failing to disclose the funding sources of Neurontin-related research and educational events;
  • Failing to require speakers at such educational events who have financial relationships with Warner-Lambert or Pfizer to disclose their relationship and whether they were paid for speaking;
  • Failing to comply with the previously-voluntary Pharmaceutical Research and Manufacturers of America Code regarding payments, gifts and remuneration to health-care providers;
  • Failing to comply with the previously-voluntary Accreditation Council for Continuing Medical Education Guidelines;
  • Misrepresenting the credentials of sales, medical and technical personnel;
  • Providing information that is misleading or lacking in fair balance to drug reference compendia; and
  • Violating federal anti-kickback laws.

(Filed May 13, 2004)


Improper Disposal of Business Records


Criminal Prosecutions

  • Charles Earls, who used someone else’s Social Security number without permission to obtain a car loan, was sentenced to three years, to be served on probation, and ordered to pay fines and fees of $1,800 and to perform 140 hours of community service.